行情

MGTX

MGTX

MeiraGTx Holdings plc
NASDAQ

实时行情|Nasdaq Last Sale

14.37
-0.12
-0.79%
盘后: 14.37 0 0.00% 16:00 10/11 EDT
开盘
14.65
昨收
14.48
最高
14.79
最低
14.34
成交量
18.16万
成交额
--
52周最高
30.23
52周最低
8.53
市值
3.91亿
市盈率(TTM)
-5.4566
分时
5日
1月
3月
1年
5年

分析师评级

4位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

MGTX 新闻

  • 分析师:Uber股价持续下跌创造了绝佳的买入机会
  • 新浪美股.1天前
  • 安联:投资者越来越担心经济衰退或美股崩盘即将来临
  • 新浪美股.1天前
  • 电动汽车泡沫要破裂?“局外人”戴森发出不好的信号
  • 新浪美股.1天前
  • 全球汽车联盟遭遇"政变" 日产、雷诺本周先后更换CEO
  • 新浪美股.1天前

更多

所属板块

生物技术和医学研究
+0.89%
制药与医学研究
+0.89%

热门股票

名称
价格
涨跌幅

MGTX 简况

MeiraGTx Holdings plc is a clinical-stage therapy company. The Company develops gene therapy treatments for a range of inherited and acquired disorders. It is focused on developing therapies for ocular diseases, including rare inherited blindness, as well as Xerostomia, radiation treatment for head and neck cancers and neurodegenerative diseases, such as amyothrophic lateral sclerosis (ALS). It is also developing transformative technology to enable the use of small molecules to turn gene therapy product candidates on and off. It is focused on three areas of unmet medical needs, including inherited retinal diseases, severe forms of xerostomia and neurodegenerative diseases. Its product candidates include AAV-CNGB3, AAV-CNGA3, AAV-RPGR, AAV-RPE65, A006, AAV-AQP1 and AAV-UPF1.
展开

Webull提供MeiraGTx Holdings PLC的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。